Gynae-Oncology focuses on oncological management of cancers of the uterus, ovaries and fallopian tubes, cervix, vagina and vulva.
At Onco Life Centre, we are dedicated to supporting our patients through every aspect of care. A team of experts from Gynecology, Medical Oncology and Radiation Oncology provides a coordinated and comprehensive cancer service including cancer gene mapping and DNA sequencing on our patients’ cancer tissue, Medical Oncology, Targeted therapy, Immunotherapy, Chemotherapy and more. We have genetic counseling expertise for patients at high risk for breast and gynecologic cancers due to strong family history or inherited BRCA 1 and 2 mutations.
Targeted therapy and immunotherapy is the foundation of precision medicine in gynaecologic cancer treatment. Our Oncologists are able to specifically design unique treatment plans for our patients. By targeting specific genes and proteins that are involved in driving cancer survival and progression, our patients at Onco Life Centre are experiencing significant and sustained improvements in their cancer responses and living longer.
At Onco Life Centre, we have made it our mission to improve the everyday lives of our patients. Our Oncologists and Pharmacists will seek to identify Compassionate Drug Access Programs that allows pre-approved new drugs outside clinical trials (and prior to product launch) for our patients who do not have satisfactory therapy options available. Click to find out more about treatment using Targeted Therapies and Immunotherapies.
Cervical cancer is cancer that starts in the neck of the womb (the cervix). Click here to find out more about treatment options.
Epithelial ovarian cancer accounts for 85 to 90% of ovarian cancers. Ovarian cancer is the seventh most common cancer among women. Click here to find out more about treatment options.
The uterus or womb is the pear shaped muscular bag that holds a baby during pregnancy. Most womb cancers start in the lining of the womb. They are also called uterine or endometrial cancer. Click here to find out more about treatment options.
Primary peritoneal cancer
PPC is a relatively rare cancer that develops most commonly in women. PPC is a close relative of epithelial ovarian cancer.
Vaginal cancer is very rare. It starts in the vagina that connects the external genitalia to uterus. It is more common in older women.
Vulval cancer is a rare cancer. It includes the inner and outer lips of the vagina, the clitoris and opening of the vagina and its glands.